Skip to content
desktop-test2

Latest news and updates from Booster

October 29, 20233 min read

Empowering Parents through enhanced KiwiSaver support

A recent report commissioned by Office of Retirement Commissioner found that the average KiwiSaver balance for women is 25% lower than for ...
Start Reading
October 29, 20232 min read

6 Practical Tips to Help you Become a Money Trailblazer

Whether you're saving for a car or a new phone, learning how to handle your money is nothing less than a superpower. Here’s 6 tips to get ...
Start Reading
October 29, 20235 min read

Calculating the Risk of Co-Signing a Loan

Check, double check and triple check any lending agreements before co-signing for whānau or friends, as tighter lending controls.
Start Reading
October 29, 20231 min read

Market activity and your KiwiSaver balance

Wondering what the best course of action is to take for your KiwiSaver with market volatility? Read more.
Start Reading
October 29, 20231 min read

Ethical investing in New Zealand

Ethical investing is an area of interest for many KiwiSaver investors looking to align their investment options with their personal values. ...
Start Reading
October 29, 20235 min read

New exclusions to Booster’s socially responsible investment funds

Booster has updated our socially responsible investment funds with six new exclusions, taking our total number of exclusions to 15. Find ...
Start Reading
October 29, 20234 min read

Insurance – for peace of mind

Thinking about insurance? People can be wary about risk insurance products – such as income, trauma or life insurance. Find out more.
Start Reading
October 29, 20232 min read

The importance of financial advice during market volatility

The FMA have released a report using data provided by seven KiwiSaver scheme providers. We explore the findings and unpack the long-term ...
Start Reading
October 29, 20232 min read

Amaroq Therapeutics secures $14 million investment for new cancer drug

Amaroq Therapeutics, part of NZ Innovation Booster's portfolio, has secured $14 million in backing to help develop a new kind of targeted ...
Start Reading